PDS Biotechnology Corporation
PDSB
$1.29
-$0.01-0.77%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 4.14% | 15.68% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -16.28% | 23.71% | |||
| Operating Income | 16.28% | -23.71% | |||
| Income Before Tax | 2.33% | -21.46% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -11.13% | -6.75% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -11.13% | -6.75% | |||
| EBIT | 16.28% | -23.71% | |||
| EBITDA | 16.31% | -23.76% | |||
| EPS Basic | 1.91% | 1.23% | |||
| Normalized Basic EPS | 13.76% | -12.37% | |||
| EPS Diluted | 1.91% | 1.23% | |||
| Normalized Diluted EPS | 13.76% | -12.37% | |||
| Average Basic Shares Outstanding | 13.28% | 8.09% | |||
| Average Diluted Shares Outstanding | 13.28% | 8.09% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||